E-LIB Suche - Ergebnisse für: Lufkin, Bradley

1

Incidence rates of thrombosis with thrombocytopenia syndrom..:

Lloyd, Patricia C. ; Lufkin, Bradley ; Moll, Keran...
Vaccine. 42 (2024) 8 - p. 2004-2010 , 2024

2

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Prevent..:

Payne, Amanda B. ; Novosad, Shannon ; Wiegand, Ryan E....
MMWR. Morbidity and Mortality Weekly Report. 73 (2024) 1 - p. 16-23 , 2024

Link: https://doi.org/10.15585..

3

Surveillance of COVID-19 vaccine safety among elderly perso..:

Wong, Hui-Lee ; Tworkoski, Ellen ; Ke Zhou, Cindy...
Vaccine. 41 (2023) 2 - p. 532-539 , 2023

Link: https://doi.org/10.1016/..

4

Background rates of adverse events of special interest for ..:

Moll, Keran ; Lufkin, Bradley ; Fingar, Kathryn R....
Vaccine. 41 (2023) 2 - p. 333-353 , 2023

Link: https://doi.org/10.1016/..

5

1173. Risk of Pneumococcal Disease and Rate of Pneumococcal..:

Kobyashi, Miwako ; Andrejko, Kristin ; Zielinski, Lindsay...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

Disparities in erythropoiesis-stimulating agent use after c..:

Wong, Hui-Lee ; Zhang, Rongmei ; Lufkin, Bradley...
Drugs & Therapy Perspectives. 39 (2022) 1 - p. 29-39 , 2022

Link: https://doi.org/10.1007/..

7

Trends in Erythropoiesis‐stimulating agent use and blood tr..:

Vega, Amarilys ; Zhang, Rongmei ; Wong, Hui‐Lee...
Pharmacoepidemiology and Drug Safety. 30 (2021) 5 - p. 626-635 , 2021

Link: https://doi.org/10.1002/..

8

Recombinant Zoster Vaccine (Shingrix): Real-World Effective..:

Izurieta, Hector S ; Wu, Xiyuan ; Forshee, Richard...
Clinical Infectious Diseases. 73 (2021) 6 - p. 941-948 , 2021

Link: https://doi.org/10.1093/..

9

Guillain-Barré Syndrome After High-Dose Influenza Vaccine A..:

Perez-Vilar, Silvia ; Hu, Mao ; Weintraub, Eric...
The Journal of Infectious Diseases. 223 (2020) 3 - p. 416-425 , 2020

Link: https://doi.org/10.1093/..

10

Surveillance for Guillain-Barré syndrome after influenza va..:

Perez-Vilar, Silvia ; Wernecke, Michael ; Arya, Deepa...
Vaccine. 37 (2019) 29 - p. 3856-3865 , 2019

Link: https://doi.org/10.1016/..

11

Surveillance for Guillain-Barré syndrome after 2015–2016 an..:

Arya, Deepa P. ; Said, Maria A. ; Izurieta, Hector S....
Vaccine. 37 (2019) 43 - p. 6543-6549 , 2019

Link: https://doi.org/10.1016/..

12

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Prevent..:

Payne, Amanda B ; Novosad, Shannon ; Wiegand, Ryan E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794061/. , 2024

Link: http://www.ncbi.nlm.nih...

13

Risk of Guillain-Barré Syndrome Following Recombinant Zoste..:

Goud, Ravi ; Lufkin, Bradley ; Duffy, Jonathan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561433/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Guillain-Barré Syndrome After High-Dose Influenza Vaccine A..:

Perez-Vilar, Silvia ; Hu, Mao ; Weintraub, Eric...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882024/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Spaces and triangles of the head and neck:

Bielamowicz, Steven A. ; Storper, Ian S. ; Jabour, Bradley A...
Head & Neck. 16 (1994) 4 - p. 383-388 , 1994

Link: https://doi.org/10.1002/..